Latest News
Azalea Health, Prognosis Innovation Healthcare Merge to Solidify Position in Rural Health Sector
Thursday 12 October 2017

12 October 2017 - Georgia, US-based healthcare solutions and services provider Azalea Health and Texas, US-based electronic health records provider Prognosis Innovation Healthcare have merged to support a care continuum platform in for rural and community hospitals, the company said.

Terms of the transaction were not disclosed.

Azalea will add close to 40 hospitals to its user base and leverage Prognosis' expertise and experience to grow and service the rural and community hospital market segments.

Azalea Health said bringing Azalea and Prognosis together can help providers create a single medical record that follows patients throughout their healthcare experience.

Rural hospitals, clinics, and ambulatory practices will now be able to create clinical, financial and quality-driven outcomes with a single platform that lets services be pushed to the lowest cost provider in that continuum.

Azalea Health is a provider of fully integrated, technology-enabled healthcare solutions and managed services for ambulatory physician practices, rural health clinics, and community and critical-access hospitals.

Azalea's comprehensive portfolio includes integrated electronic health records, practice management, Azalea M mobile platform integrated with Apple HealthKit, as well as complete telehealth, revenue cycle performance and professional consulting services.

Prognosis Innovation Healthcare helps hospitals achieve system-wide user adoption, which results in better care coordination, improved communication, enhanced patient safety, increased charge capture and augmented hospital operations.

The company's solution suite--inpatient, ambulatory, ED and financial systems--is built on a web-native platform.
Details
Date Published: 12/10/2017
Target: Prognosis Innovation Healthcare
Country: USA
Sector: Healthcare
Type: Merger
Financing:
Status: Closed
Vendor:
Buyer: Azalea Health
Comment:
Terms of the deal were not disclosed

Options